These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
209 related items for PubMed ID: 17428079
1. Glycoprotein microarrays with multi-lectin detection: unique lectin binding patterns as a tool for classifying normal, chronic pancreatitis and pancreatic cancer sera. Zhao J, Patwa TH, Qiu W, Shedden K, Hinderer R, Misek DE, Anderson MA, Simeone DM, Lubman DM. J Proteome Res; 2007 May; 6(5):1864-74. PubMed ID: 17428079 [Abstract] [Full Text] [Related]
2. Screening of glycosylation patterns in serum using natural glycoprotein microarrays and multi-lectin fluorescence detection. Patwa TH, Zhao J, Anderson MA, Simeone DM, Lubman DM. Anal Chem; 2006 Sep 15; 78(18):6411-21. PubMed ID: 16970316 [Abstract] [Full Text] [Related]
8. Pancreatic cancer serum detection using a lectin/glyco-antibody array method. Li C, Simeone DM, Brenner DE, Anderson MA, Shedden KA, Ruffin MT, Lubman DM. J Proteome Res; 2009 Feb 15; 8(2):483-92. PubMed ID: 19072160 [Abstract] [Full Text] [Related]
11. C reactive protein in pancreatic cancer and chronic pancreatitis. Basso D, Fabris C, Meani A, Del Favero G, Vianello D, Angonese C, Meggiato T, Bellinvia S, Fogar P, Petrin P. Ann Clin Res; 1988 Feb 15; 20(6):414-6. PubMed ID: 3218913 [Abstract] [Full Text] [Related]
12. Biomarker identification in human pancreatic cancer sera. Hanas JS, Hocker JR, Cheung JY, Larabee JL, Lerner MR, Lightfoot SA, Morgan DL, Denson KD, Prejeant KC, Gusev Y, Smith BJ, Hanas RJ, Postier RG, Brackett DJ. Pancreas; 2008 Jan 15; 36(1):61-9. PubMed ID: 18192883 [Abstract] [Full Text] [Related]
13. Lectin microarray profiling of metastatic breast cancers. Fry SA, Afrough B, Lomax-Browne HJ, Timms JF, Velentzis LS, Leathem AJ. Glycobiology; 2011 Aug 15; 21(8):1060-70. PubMed ID: 21507904 [Abstract] [Full Text] [Related]
14. Proteomics-based identification of DEAD-box protein 48 as a novel autoantigen, a prospective serum marker for pancreatic cancer. Xia Q, Kong XT, Zhang GA, Hou XJ, Qiang H, Zhong RQ. Biochem Biophys Res Commun; 2005 May 06; 330(2):526-32. PubMed ID: 15796914 [Abstract] [Full Text] [Related]
18. Multiplexed analysis of glycan variation on native proteins captured by antibody microarrays. Chen S, LaRoche T, Hamelinck D, Bergsma D, Brenner D, Simeone D, Brand RE, Haab BB. Nat Methods; 2007 May 06; 4(5):437-44. PubMed ID: 17417647 [Abstract] [Full Text] [Related]
19. A strategy for discovery of cancer glyco-biomarkers in serum using newly developed technologies for glycoproteomics. Narimatsu H, Sawaki H, Kuno A, Kaji H, Ito H, Ikehara Y. FEBS J; 2010 Jan 06; 277(1):95-105. PubMed ID: 19919546 [Abstract] [Full Text] [Related]
20. New MUC1 serum immunoassay differentiates pancreatic cancer from pancreatitis. Gold DV, Modrak DE, Ying Z, Cardillo TM, Sharkey RM, Goldenberg DM. J Clin Oncol; 2006 Jan 10; 24(2):252-8. PubMed ID: 16344318 [Abstract] [Full Text] [Related] Page: [Next] [New Search]